Suministro sucesivo de los medicamentos de inmunoterapia oncológica para el Área de Santiago de Compostela y Barbanza
Title in Spanish as published on TED.
Contract award notice published on TED on 7 Oct 2026 by Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza (Spain), CPV 33652100 Antineoplastic agents. Awarded to ROCHE FARMA, S.A., MERCK, S.L.U., REGENERON SPAIN, S.L.U. and 5 more for EUR 9,228,285.
| Notice | 690950-2026 (can-standard) |
|---|---|
| Status | Contract award |
| Published | 7 Oct 2026 |
| Buyer | Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza, Santiago de Compostela |
| Country | Spain |
| Main CPV | 33652100-6 Antineoplastic agents |
| Contract type | supplies |
| Procedure | neg wo call |
| Awarded value | EUR 9,228,285 |
| Tenders received | 1 |
Join the Pro waitlist
Pro adds monitoring, alerts and bulk exports across Initask sites. Leave your email and we will write when it opens.
Description
Suministro sucesivo de los medicamentos de inmunoterapia oncológica para el Área de Santiago de Compostela y Barbanza
Lots (8)
| Lot | Title | Estimated value | Deadline |
|---|---|---|---|
| LOT-0001 | ATEZOLIZUMAB 1.200 MG/20 ML 1 VIAL / ATEZOLIZUMAB 1.875 MG/15 ML 1 VIAL | ||
| LOT-0002 | AVELUMAB 200 MG/10 ML 1 VIAL | ||
| LOT-0003 | CEMIPLIMAB 350 MG/7 ML 1 VIAL | ||
| LOT-0004 | DOSTARLIMAB 500 MG/10 ML 1 VIAL | ||
| LOT-0005 | DURVALUMAB 120 MG/2,4 ML 1 VIAL / DURVALUMAB 500 MG/10 ML 1 VIAL | ||
| LOT-0006 | NIVOLUMAB 40 MG/4 ML 1 VIAL / NIVOLUMAB 100 MG/10 ML 1 VIAL | ||
| LOT-0007 | PEMBROLIZUMAB 100 MG/4 ML 1 VIAL | ||
| LOT-0008 | TISLELIZUMAB 100 MG/10 ML 1 VIAL |
Winners
- ROCHE FARMA, S.A. Madrid, Spain, size: large
- MERCK, S.L.U. Mollet del Valles, Spain, size: large
- REGENERON SPAIN, S.L.U. Madrid, Spain, size: large
- GLAXOSMITHKLINE, S.A. Madrid, Spain, size: large
- ASTRAZENECA FARMACÉUTICA SPAIN, S.A. Parque Tecnológico, Spain, size: large
- BRISTOL-MYERS SQUIBB, S.A.U. Madrid, Spain, size: large
- MERCK SHARP & DOHME DE ESPAÑA, S.A. Madrid, Spain, size: large
- BEONE MEDICINES ESP, S.L.U. Príncipe de Vergara, Spain, size: large
More Antineoplastic agents in Spain
SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS con principios activos daratumumab, talquetamab, glecaprevir/pibrentasvir, epcoritamab, atogepant, rimegepant, retlecitinib y cemiplimab de varios laboratorios farmacéuticos.
Award · Antineoplastic and immunomodulating agents · 7 Oct 2026 · Spain · Servicio Murciano de Salud - Junta de Compras · value EUR 27,609,248 · won by JANSSEN CILAG, S.A., ABBVIE SPAIN, S.L.U.
Suministro sucesivo del medicamento "Axicabtagen Ciloleucel"
Award · Antineoplastic agents · 29 Sep 2026 · Spain · Área Sanitaria da Coruña e Cee - Servicio Gallego de Salud · won by GILEAD SCIENCES, S.L.
Suministro sucesivo de diversos medicamentos para el tratamiento del Mieloma Múltiple (MM) para los centros hospitalarios del Área Sanitaria de Lugo, A Mariña y Monforte de Lemos
Award · Antineoplastic agents · 29 Sep 2026 · Spain · Servicio Gallego de Salud - Área Sanitaria de Lugo, A Mariña y Monforte de Lemos · value EUR 6,475,019 · won by AMGEN S.A., JANSSEN-CILAG S.A.
Suministro de adquisición del Scemblix para el Servicio de Farmacia del Hospital Universitario Ramón y Cajal.
Award · Antineoplastic agents · 21 Sep 2026 · Spain · HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL · value EUR 769,615 · won by NOVARTIS Farmacéutica S.A.,
Suministro sucesivo del medicamento Axicabtagen Ciloleucel
Award · Antineoplastic agents · 15 Sep 2026 · Spain · Servizo Galego de Saúde. Área Sanitaria de Vigo · won by GILEAD SCIENCES, S.L.
Suministro sucesivo del medicamento Axicabtagen Ciloleucel
Award · Antineoplastic agents · 15 Sep 2026 · Spain · Servizo Galego de Saúde. Área Sanitaria de Vigo · won by GILEAD SCIENCES, S.L.
Get new antineoplastic agents tenders by email
A free weekly digest of new competition notices for this CPV code and country, straight from TED.
Set up a free alert